title: Anxiety and depression after lung transplantation: Mirtazapine as a first-choice agent?
authors.forename: Paolo
authors.initials: P
authors.lastname: Fusar-Poli
authors.forename: Lazzaretti
authors.initials: L
authors.lastname: Matteo
authors.forename: De Marco
authors.initials: de M
authors.lastname: Luca
authors.forename: Pierluigi
authors.initials: P
authors.lastname: Politi
authors.forename: Mariachiara
authors.initials: M
authors.lastname: Cortesi
authors.forename: Valeri
authors.initials: V
authors.lastname: Carboni
mesh_terms: D000929:Antidepressive Agents, Tricyclic / Q000009:adverse effects / Q000627:therapeutic use*; D001008:Anxiety Disorders / Q000188:drug therapy* / Q000523:psychology; D003866:Depressive Disorder / Q000188:drug therapy* / Q000523:psychology; D004347:Drug Interactions; D006801:Humans; D016040:Lung Transplantation / Q000523:psychology*; D008803:Mianserin / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D000078785:Mirtazapine; D011183:Postoperative Complications / Q000188:drug therapy* / Q000523:psychology; D007319:Sleep Initiation and Maintenance Disorders / Q000188:drug therapy / Q000523:psychology
chemical_list: D000929:Antidepressive Agents, Tricyclic; D008803:Mianserin; D000078785:Mirtazapine